Avian influenza has become endemic worldwide, threatening poultry production, food security, and human health. Ceva Animal Health, the world’s fifth-largest animal health company, is promoting vaccination as a critical tool to contain outbreaks and support global prevention efforts.
Momentum is growing internationally. The World Organisation for Animal Health (WOAH) passed Resolution 29 in May 2025, while the FAO and HealthforAnimals are discussing a global vaccine pre-qualification scheme. France has already shown the impact: a nationwide campaign reduced outbreaks and boosted poultry production by 12.1% in 2024, making vaccination a permanent annual program.
Ceva has been leading innovation for more than a decade, developing hatchery vaccines that provide lifelong protection to broilers and layers, as well as Europe’s first nucleotide vaccine for ducks. The company’s vaccines incorporate DIVA technology, allowing authorities to distinguish between infected and vaccinated birds, a vital step for surveillance.
“Vaccination, combined with robust biosecurity measures, helps secure the future of global poultry production, food security and human health,” said a Ceva spokesperson.